5-HT7 receptor antagonist SB269970 attenuates seizures by modulating NO/cGMP signaling pathway and neuroinflammation in a pentylenetetrazol-induced epilepsy model in rats
Nitric Oxide · 2025-12 · 159 · 78-88
DOI: 10.1016/j.niox.2025.09.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nitric Oxide, 2025-12. Verfasst von Handan Gunes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Physiology, Medicine Faculty, Sivas Cumhuriyet University, Sivas, Turkey. Hauptthemen laut MEDLINE: Nitric Oxide, Cyclic GMP, Receptors, Serotonin, Epilepsy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Sivas Cumhuriyet Üniversitesi.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Physiology, Medicine Faculty, Sivas Cumhuriyet University, Sivas, Turkey.
- Departments of Physiology, Medicine Faculty, Sivas Cumhuriyet University, Sivas, Turkey. Electronic address: eozdemir@cumhuriyet.edu.tr.
Förderung
- Sivas Cumhuriyet Üniversitesi
Zitieren
APA
Gunes, H., Ozdemir, E., & Taskiran, A. S. (2025). 5-HT7 receptor antagonist SB269970 attenuates seizures by modulating NO/cGMP signaling pathway and neuroinflammation in a pentylenetetrazol-induced epilepsy model in rats. Nitric Oxide, 159, 78-88. https://doi.org/10.1016/j.niox.2025.09.006
Vancouver
Gunes H, Ozdemir E, Taskiran AS. 5-HT7 receptor antagonist SB269970 attenuates seizures by modulating NO/cGMP signaling pathway and neuroinflammation in a pentylenetetrazol-induced epilepsy model in rats. Nitric Oxide. 2025;159:78-88. doi:10.1016/j.niox.2025.09.006
BibTeX
@article{Gunes2025,
author = {Gunes, Handan and Ozdemir, Ercan and Taskiran, Ahmet Sevki},
title = {5-HT7 receptor antagonist SB269970 attenuates seizures by modulating NO/cGMP signaling pathway and neuroinflammation in a pentylenetetrazol-induced epilepsy model in rats},
journal = {Nitric Oxide},
year = {2025},
volume = {159},
pages = {78--88},
doi = {10.1016/j.niox.2025.09.006}
}
EUVIMED